$241.01
-3.37-1.38%
After hour: 9:29 AM EDT
Comments
Loading...
Guidance e previsioni
AbbVie fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
07/31/2025 | ABBV | AbbVie | FY | 2025 | $11.88 | $12.08 | $11.97 | — | — | — | |
07/03/2025 | ABBV | AbbVie | Q2 | 2025 | $2.84 | $2.88 | — | — | — | — | |
07/03/2025 | ABBV | AbbVie | FY | 2025 | $11.67 | $11.87 | — | — | — | — | |
04/25/2025 | ABBV | AbbVie | FY | 2025 | $12.09 | $12.29 | $12.18 | — | — | — | |
04/03/2025 | ABBV | AbbVie | Q1 | 2025 | $2.34 | $2.38 | $2.51 | — | — | — | |
04/03/2025 | ABBV | AbbVie | FY | 2025 | $11.99 | $12.19 | $12.28 | — | — | — | |
01/31/2025 | ABBV | AbbVie | FY | 2025 | $12.12 | $12.32 | $12.13 | — | — | — | |
01/06/2025 | ABBV | AbbVie | FY | 2024 | $10.02 | $10.06 | $10.94 | — | — | — | |
01/06/2025 | ABBV | AbbVie | Q4 | 2024 | $2.06 | $2.10 | $2.98 | — | — | — | |
10/30/2024 | ABBV | AbbVie | Q4 | 2024 | $2.94 | $2.98 | $2.95 | $14.80B | $14.80B | $14.64B | |
10/30/2024 | ABBV | AbbVie | FY | 2024 | $10.90 | $10.94 | $10.85 | — | — | — | |
10/03/2024 | ABBV | AbbVie | FY | 2024 | $10.71 | $10.91 | $10.88 | — | — | — | |
10/03/2024 | ABBV | AbbVie | Q3 | 2024 | $2.92 | $2.96 | $2.95 | — | — | — | |
08/01/2024 | ABBV | AbbVie | FY | 2024 | $10.71 | $10.91 | $10.87 | — | — | — | |
08/01/2024 | ABBV | AbbVie | Q3 | 2024 | $2.92 | $2.96 | $2.94 | — | — | — | |
07/25/2024 | ABBV | AbbVie | FY | 2024 | $10.71 | $10.91 | $9.93 | $55.50B | $55.50B | $55.34B | |
07/25/2024 | ABBV | AbbVie | Q3 | 2024 | $2.92 | $2.96 | $2.91 | $14.20B | $14.20B | $14.22B | |
07/03/2024 | ABBV | AbbVie | FY | 2024 | $10.61 | $10.81 | $11.25 | — | — | — | |
07/03/2024 | ABBV | AbbVie | Q2 | 2024 | $2.53 | $2.57 | $3.05 | — | — | — | |
04/26/2024 | ABBV | AbbVie | FY | 2024 | $11.13 | $11.33 | $11.10 | $55.00B | $55.00B | $54.60B | |
04/26/2024 | ABBV | AbbVie | Q2 | 2024 | $3.05 | $3.09 | $2.81 | $14.00B | $14.00B | $13.57B | |
04/03/2024 | ABBV | AbbVie | Q1 | 2024 | $2.18 | $2.22 | $2.33 | — | — | — | |
04/03/2024 | ABBV | AbbVie | FY | 2024 | $10.97 | $11.17 | $11.19 | — | — | — | |
02/12/2024 | ABBV | AbbVie | FY | 2024 | $11.05 | $11.25 | $11.18 | — | — | — | |
02/12/2024 | ABBV | AbbVie | Q1 | 2024 | $2.26 | $2.30 | $2.39 | — | — | — | |
02/02/2024 | ABBV | AbbVie | Q1 | 2024 | $2.30 | $2.34 | $2.31 | $11.90B | $11.90B | $11.37B | |
02/02/2024 | ABBV | AbbVie | FY | 2024 | $11.05 | $11.25 | $11.24 | $54.20B | $54.20B | $49.94B | |
01/05/2024 | ABBV | AbbVie | FY | 2023 | $11.04 | $11.08 | $11.22 | — | — | — | |
01/05/2024 | ABBV | AbbVie | Q4 | 2023 | $2.72 | $2.76 | $2.90 | — | — | — | |
10/27/2023 | ABBV | AbbVie | FY | 2023 | $11.19 | $11.23 | $10.42 | — | — | — | |
10/27/2023 | ABBV | AbbVie | FY | 2024 | $11.00 | $11.00 | $10.45 | — | — | — | |
10/04/2023 | ABBV | AbbVie | FY | 2023 | $10.86 | $11.06 | $11.07 | — | — | — | |
10/04/2023 | ABBV | AbbVie | Q3 | 2023 | $2.76 | $2.86 | $2.88 | — | — | — | |
07/27/2023 | ABBV | AbbVie | Q3 | 2023 | $2.80 | $2.90 | $2.82 | $13.70B | $13.70B | $13.35B | |
07/27/2023 | ABBV | AbbVie | FY | 2023 | $10.90 | $11.10 | $10.87 | — | — | — | |
07/06/2023 | ABBV | AbbVie | FY | 2023 | $10.57 | $10.97 | $10.08 | — | — | — | |
07/06/2023 | ABBV | AbbVie | Q2 | 2023 | $2.75 | $2.85 | $2.69 | — | — | — | |
04/27/2023 | ABBV | AbbVie | Q2 | 2023 | $2.90 | $3.00 | $2.85 | $13.50B | $13.50B | $13.36B | |
04/27/2023 | ABBV | AbbVie | FY | 2023 | $10.72 | $11.12 | $10.94 | — | — | — | |
04/05/2023 | ABBV | AbbVie | FY | 2023 | $10.62 | $11.02 | $11.07 | — | — | — | |
04/05/2023 | ABBV | AbbVie | Q1 | 2023 | $2.31 | $2.41 | $2.55 | — | — | — | |
02/09/2023 | ABBV | AbbVie | Q1 | 2023 | $2.39 | $2.49 | $3.08 | $11.80B | $11.80B | $13.36B | |
02/09/2023 | ABBV | AbbVie | FY | 2024 | $10.70 | — | — | — | — | — | |
02/09/2023 | ABBV | AbbVie | FY | 2023 | $10.70 | $11.10 | $11.65 | $52.00B | $52.00B | $54.21B | |
01/06/2023 | ABBV | AbbVie | FY | 2022 | $13.70 | $13.74 | $13.85 | — | — | — | |
01/06/2023 | ABBV | AbbVie | Q4 | 2022 | $3.51 | $3.55 | $3.67 | — | — | — | |
10/28/2022 | ABBV | AbbVie | FY | 2022 | $13.84 | $13.88 | $13.86 | $58.20B | $58.20B | $58.92B | |
10/28/2022 | ABBV | AbbVie | Q4 | 2022 | $3.65 | $3.69 | $3.75 | $15.20B | $15.20B | $15.78B | |
10/05/2022 | ABBV | AbbVie | FY | 2022 | $13.76 | $13.96 | $13.87 | — | — | — | |
10/05/2022 | ABBV | AbbVie | Q3 | 2022 | $3.53 | $3.57 | $3.60 | — | — | — | |
07/29/2022 | ABBV | AbbVie | Q3 | 2022 | $3.55 | $3.59 | $3.67 | $14.80B | $14.80B | $15.28B | |
07/29/2022 | ABBV | AbbVie | FY | 2022 | $13.78 | $13.98 | $13.91 | $58.90B | $58.90B | $59.59B | |
07/06/2022 | ABBV | AbbVie | Q2 | 2022 | $3.24 | $3.28 | $3.43 | — | — | — | |
07/06/2022 | ABBV | AbbVie | FY | 2022 | $13.78 | $13.98 | $14.01 | — | — | — | |
04/29/2022 | ABBV | AbbVie | Q2 | 2022 | $3.38 | $3.42 | $3.47 | $14.60B | $14.60B | $14.77B | |
04/29/2022 | ABBV | AbbVie | FY | 2022 | $13.92 | $14.12 | $14.11 | $59.40B | $59.40B | $60.04B | |
02/02/2022 | ABBV | AbbVie | FY | 2022 | $14.00 | $14.20 | $13.99 | — | — | — | |
10/29/2021 | ABBV | AbbVie | FY | 2021 | $12.63 | $12.67 | $12.59 | $56.20B | $56.20B | $56.28B | |
10/29/2021 | ABBV | AbbVie | Q4 | 2021 | $3.24 | $3.28 | $3.30 | $15.00B | $15.00B | $15.01B | |
07/30/2021 | ABBV | AbbVie | FY | 2021 | $12.52 | $12.62 | $12.60 | — | — | — | |
04/30/2021 | ABBV | AbbVie | Q2 | 2021 | $3.05 | $3.09 | $3.06 | $13.60B | $13.60B | $13.52B | |
04/30/2021 | ABBV | AbbVie | FY | 2021 | $12.37 | $12.57 | $12.45 | $55.90B | $55.90B | $55.34B | |
02/03/2021 | ABBV | AbbVie | FY | 2021 | $12.32 | $12.52 | $12.18 | — | — | — |
FAQ
Qual è la guidance più recente per AbbVie (ABBV)?
Le ultime previsioni per AbbVie (ABBV) sono state riportate il luglio 31, 2025 per l'intero anno 2025. L'azienda ha fornito una previsione di utili per azione nell'intervallo da $11.88 a $12.08, rispetto all'EPS stimato di $11.97. Inoltre, AbbVie ha previsto ricavi tra $0.00B e $0.00B per il trimestre.
Sfoglia guidance e previsioni su tutte le azioni.